Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Expression analysis of human TL1A on Raji/Membrane-Bound Human TL1A Stable Cell Line by FACS.
Cell surface staining was performed on Raji/Membrane-Bound Human TL1A Stable Cell Line or negative control cell using anti-human TL1A antibody followed by staining with PE anti-human IgG Fc antibody.
Expression analysis of human TL1A on HEK293/Membrane-Bound Human TL1A Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Membrane-Bound Human TL1A Stable Cell Line or negative control cell using anti-human TL1A antibody followed by staining with PE anti-human IgG Fc antibody.
Human TL1A Protein, Fc Tag (Cat. No. TLA-H5263) immobilized on CM5 Chip can bind Human DcR3, Fc Tag (Cat. No. TNB-H5255) with an affinity constant of 0.621 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| RG-6631 | RG6631; RG-6631 | Phase 3 Clinical | F. Hoffmann-La Roche Ltd | Colitis, Ulcerative | Details |
| Tulisokibart | PRA-023; MK-7240; PRA023 | Phase 3 Clinical | Prometheus Biosciences Inc, Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Colitis, Ulcerative; Scleroderma, Diffuse; Crohn Disease | Details |
| Duvakitug | TEV574; TEV-574; TEV-48574; TEV-574; TEV574; SAR447189; SAR-447189 | Phase 2 Clinical | Teva Pharmaceutical Industries Ltd | Asthma; Colitis, Ulcerative; Crohn Disease | Details |
| XmAb-942 | XmAb942; XmAb-942 | Phase 2 Clinical | Xencor Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative | Details |
| RVT-3101 | PF-06480605; PF 6480605; RVT-3101 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease | Details |
| PF-07261271 | PF-07261271 | Phase 1 Clinical | Pfizer Inc | Inflammatory Bowel Diseases | Details |
| SPY-002 | SPY002-091; SPY002 072; SPY-002; PR-010 | Phase 1 Clinical | Paragon Therapeutics Inc | Details | |
| SPY002-072 | SPY002-072 | Phase 1 Clinical | Spyre Therapeutics Inc, Novotech (Australia) Pty Ltd | Details | |
| BCD-261 | BCD-261 | Phase 1 Clinical | BIOCAD JSC | Colitis, Ulcerative; Crohn Disease | Details |
| Next-generation anti-TL1A antibody(Telavant) | Phase 1 Clinical | Telavant Inc | Fibrosis; Inflammation | Details |
This web search service is supported by Google Inc.
A-Z
